Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boehringer ingelheim
2
×
boston blog main
boston top stories
eli lilly
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
sanofi
2
×
abbvie
acceleron pharma
acid sphingomyelinase deficiency
allergan
alzheimer's disease
anika therapeutics
annovis bio
arcutis biotherapeutics
baricitinib
beam therapeutics
bill & melinda gates foundation
biofourmis
biointellisense
biontech
biotech
biotechnology industry organization
black diamond therapeutics
boston
boulder/denver blog main
boulder/denver top stories
bruce goldsmith
cancer
cancer drug
chronic kidney disease
chronic rhinosinusitis
clinical trials
clostridoides-difficile
crispr
curevac
What
bio
companies
2
×
bets
black
cancer
comes
continue
cut
date
deal
debut
diamond
diamond’s
effective
enticed
evidence
hasn’t
indication
latest
leading
life
mammoth
march
medicines
messenger
molecules
moves
mrna
multiple
new
ohana’s
pharmaceutical
pop
primarily
promise
proven
rna
roundup
sanofi
science
Language
unset
Current search:
sanofi
×
companies
×
" boehringer ingelheim "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines